Biogen (NASDAQ:BIIB) has agreed to pay Neomorph up to $1.45B plus royalties on any future products as part of a new collaboration deal for the discovery and development of molecular glue degraders for ...
The positions in the table below reflect the Neomorph, Inc's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results